Leukotriene receptor antagonists for chronic urticaria: a systematic review (Q33593785)

28 July 2017

title

Leukotriene receptor antagonists for chronic urticaria: a systematic review (English)

1 reference

28 July 2017

1 reference

1 reference

1 reference

Nipun Lakshitha de Silva

1

0 references

Senaka Rajapakse

object named as

Senaka Rajapakse

5

0 references

Chaturaka Rodrigo

object named as

Chaturaka Rodrigo

4

0 references

author name string

Hasitha Damayanthi

2

1 reference

28 July 2017

Anoja Chamarie Rajapakse

3

1 reference

28 July 2017

publication date

7 May 2014

1 reference

Allergy, Asthma & Clinical Immunology

28 July 2017

published in

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

24

1 reference

Effects of omalizumab treatment in patients with refractory chronic urticaria

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

Antileukotriene drugs: clinical application, effectiveness and safety

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

Montelukast treatment of urticaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

Chronic urticaria: pathogenesis and treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

21 June 2018

Management of urticaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

Long-term benefits of omalizumab in a patient with severe non-allergic asthma

21 June 2018

1 reference

https://api.crossref.org/works/10.1186/1710-1492-10-24

Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1710-1492-10-24

Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1710-1492-10-24

Zafirlukast has no beneficial effects in the treatment of chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1710-1492-10-24

Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1710-1492-10-24

The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1710-1492-10-24

Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

30 October 2018

Urticaria and angioedema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4016797

10 December 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24817895

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24817895

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24817895

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1710-1492-10-24

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1710-1492-10-24

9 September 2019

1 reference

28 July 2017

1 reference